Lee Jacky W Y, Lai Jimmy S M
Dennis Lam and Partners Eye Center, Central, Hong Kong.
Department of Ophthalmology, The University of Hong Kong, Pokfulam, Hong Kong.
Hong Kong Med J. 2016 Apr;22(2):165-70. doi: 10.12809/hkmj154641. Epub 2016 Mar 11.
Selective laser trabeculoplasty was first introduced to Hong Kong in 2004 for intra-ocular pressure lowering in the treatment of primary glaucoma. Since then, it has gained popularity as an alternative to anti-glaucoma medications and as a bridging therapy prior to more invasive glaucoma surgeries because of the high safety profile of the laser.
An Ovid search was performed using "selective laser trabeculoplasty" as the key word, which identified 190 unique articles; 24 reviews and/or meta-analyses were excluded. All remaining abstracts of original articles were in English. This review particularly focuses on the local population by summarising the findings from peer-reviewed publications that involved a Hong Kong Chinese population.
This review addresses some of the clinically relevant questions relating to selective laser trabeculoplasty including laser application, optimal energy, efficacies and success rates among different glaucoma subtypes, predictors of success, adverse effects, and intra-ocular pressure fluctuation after selective laser trabeculoplasty.
选择性激光小梁成形术于2004年首次引入香港，用于降低眼压以治疗原发性青光眼。从那时起，由于该激光具有高度的安全性，它作为抗青光眼药物的替代方法以及在更具侵入性的青光眼手术之前的一种过渡性治疗方法而受到欢迎。
以“选择性激光小梁成形术”为关键词进行Ovid检索，共识别出190篇独特的文章；排除24篇综述和/或荟萃分析。所有剩余原始文章的摘要均为英文。本综述通过总结来自涉及香港华人人群的同行评审出版物的研究结果，特别关注当地人群。
本综述探讨了一些与选择性激光小梁成形术相关的临床问题，包括激光应用、最佳能量、不同青光眼亚型的疗效和成功率、成功的预测因素、不良反应以及选择性激光小梁成形术后的眼压波动。
